Alvotech And Dr. Reddy's Sign Agreement To Co-Develop And Commercialize Biosimilar To Keytruda Worldwide

Under the terms of the agreement, the parties will be jointly responsible for developing and manufacturing the biosimilar candidate and sharing costs and responsibilities. Subject to certain exceptions, each party will have the right to commercialize the product globally.